Condition
Irvine-Gass Syndrome
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Terminated1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03396861Phase 1TerminatedPrimary
Treatment of Macular Edema After Cataract Surgery with Subconjunctival Aflibercept
NCT05337332Phase 2Unknown
Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases
NCT03383328Phase 4Completed
Study for Optimizing Anti-inflammatory Prophylaxis
NCT03404323Completed
"Cataract Surgery in Eyes With Epiretinal Membrane"
Showing all 4 trials